Y-Intercept (HK)’s ANI Pharmaceuticals ANIP Stock Holding History

Y-Intercept (HK)’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.86M	Buy	34,505 +25,082	+266%	+$2.01M	0.06%	503
2026 Q1	$725K	Sell	9,423 -35,983	-79%	-$2.81M	0.01%	1147
2025 Q4	$3.58M	Buy	45,406 +37,716	+490%	+$3.27M	0.08%	345
2025 Q3	$704K	Buy	+7,690	New	+$627K	0.02%	1129
2024 Q4	–	Sell	-6,781	Closed	-$405K	–	1153
2024 Q3	$405K	Buy	+6,781	New	+$414K	0.02%	879

Other funds holding ANIP

MMA

Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

OLA

Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

Y-Intercept (HK)'s ANIP Position: Q2 2026 in Review

Y-Intercept (HK) increased its ANI Pharmaceuticals (ANIP) stake by 266% in Q2 2026, buying an estimated $2.01M and bringing the position to 34,505 shares worth $2.86M. The position accounts for 0.06% of the portfolio, ranked #503.

Y-Intercept (HK) first reported a position in ANIP in Q3 2024 and has held it in 5 quarters since. The position peaked at $3.58M in Q4 2025. 39 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Y-Intercept (HK) held 34,505 shares of ANI Pharmaceuticals worth $2.86M as of Q2 2026.
Y-Intercept (HK) bought 25,082 ANI Pharmaceuticals shares in Q2 2026, an estimated $2.01M.
ANI Pharmaceuticals made up 0.06% of Y-Intercept (HK)'s portfolio in Q2 2026, its #503 holding.
Y-Intercept (HK) first reported a position in ANI Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
Y-Intercept (HK)'s ANI Pharmaceuticals position peaked at $3.58M in Q4 2025.
39 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.